Resources for the Community:
___________________________________________________________________
Ro - Telehealth for GLP1 weight management
_____________________________________________________________________
In this timely bonus episode of The Plus SideZ Podcast, we dive into the FDA’s decision to end the tirzepatide shortage, its 60-90 day grace period for compounding pharmacies, and what this means for patients relying on affordable access to GLP-1 medications like Zepbound and Mounjaro. Joining us is Scott Brunner, CEO of the Alliance for Pharmacy Compounding, to discuss the impact of this ruling, safety concerns, and the role of compounded medications in obesity care.
We also explore the new PBM reform bill, aiming to address access and affordability challenges for patients. Whether you’re a patient, provider, or advocate, this episode unpacks the critical issues shaping the future of obesity and diabetes treatments.
Tune in to learn how to navigate these changes and make informed decisions for your health. #GLP1 #Tirzepatide #ObesityCare #PBMReform
______________________________________________________________________
⭐️Mounjaro Stanley⭐️
griffintumblerco.Etsy.com
Use code PODCAST10 for $ OFF
______________________________________________________________________
Join this channel to get access to perks:
/ @theplussidez
______________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #good keto detox pills #diet pills for teens #keto f1 gummies
FDA Says Popular ‘Weight Loss Meds’ No Longer in Shortage: What Patients Need to Know [D-fxAC7bm1h]
Resources for the Community:
___________________________________________________________________
Ro - Telehealth for GLP1 weight management
_____________________________________________________________________
In this timely bonus episode of The Plus SideZ Podcast, we dive into the FDA’s decision to end the tirzepatide shortage, its 60-90 day grace period for compounding pharmacies, and what this means for patients relying on affordable access to GLP-1 medications like Zepbound and Mounjaro. Joining us is Scott Brunner, CEO of the Alliance for Pharmacy Compounding, to discuss the impact of this ruling, safety concerns, and the role of compounded medications in obesity care.
We also explore the new PBM reform bill, aiming to address access and affordability challenges for patients. Whether you’re a patient, provider, or advocate, this episode unpacks the critical issues shaping the future of obesity and diabetes treatments.
Tune in to learn how to navigate these changes and make informed decisions for your health. #GLP1 #Tirzepatide #ObesityCare #PBMReform
______________________________________________________________________
⭐️Mounjaro Stanley⭐️
griffintumblerco.Etsy.com
Use code PODCAST10 for $ OFF
______________________________________________________________________
Join this channel to get access to perks:
/ @theplussidez
______________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #good keto detox pills #diet pills for teens #keto f1 gummies